Jeroen van der Laak, Geert Litjens and Thijs Eijsvogels have been awarded the Radboud Science Award 2018. The awardees receive the award for the quality of their scientific research. In the coming year, the winners will be given the opportunity to translate their research into teaching materials for primary education.The other 2018 winner is neuroscientist Hanneke den Ouden.
The Radboud Science Awards are awarded annually to Radboud scientists who have made the best and most interesting proposal to translate their research into primary school activities.
Jeroen van der Laak and Geert Litjens: Smart computers helping doctors
How could artificial intelligence help diagnose illnesses? Jeroen van der Laak and Geert Litjens, researchers at the Department of Pathology of Radboud university medical center, are carrying out research into the subject. By providing computers with examples of what a tumour can look like under a microscope, they taught these computers to recognise tumours under a microscope as well. They discovered that the computer is just as efficient at recognising a tumour as a pathologist. Will pathologists become obsolete? Highly unlikely. However, thanks to this research, they will be able to use a computer programme to diagnose in shorter time and thus better help patients get well again.
Thijs Eijsvogels: Sports are good for you, or are they?
Everyone knows that being more active is better for your health, but is that truly the case? Thijs Eijsvogels, exercise physiology researcher, carries out research into the effects of sports on health and the blood vessels around the heart. Contrarily to what was expected, the most active athletes suffer from coronary artery calcification more often than those who are less active. However, the type of coronary artery calcification is more favourable than the type in less active athletes, which could cause the eventual risk for a heart attack to be the same or even lower.
Laureates will bring their research into classrooms
During the coming year, the laureates will develop teaching materials for primary schools together with the Science Education Hub Radboud University (WKRU) and teachers. Pupils will be taught about the research by the laureates and will get to carry out their own research within the same theme. The pupils will be guided by their own questions and curiosity.
During the award ceremony of the Radboud Science Award on 2 October, the winners will proudly present their research and be questioned by pupils from three primary school classes. Everyone is welcome to attend.
Jeroen van der Laak is member of theme Women's cancers
Geert Litjens is member of theme Urological cancers
Thijs Eijsvogels is member of theme Vascular damage
Related news items
Dealing with COVID-19 in low- and middle-income countries26 March 2020
RIHS researcher Joost Hopman believes that low-and middle-income countries should intensify their preparedness for a possible COVID-19 outbreak. This was the core message of an opinion article that he wrote at the request of the medical journal JAMA.read more
Physiotherapy is important to the recovery of patients with the coronavirus26 March 2020
Patients who have been infected with the coronavirus and admitted to the hospital for this reason should receive physiotherapy as soon as their condition allows. This is the view expressed by physiotherapists and researchers from the Radboudumc in a set of joint treatment recommendations.read more
Healthcare utilization and regional variation of end-of-life hospital care in Dutch cancer patients26 March 2020
In International Journal of Quality Health Care RIHS researcher Femke Atsma showed high healthcare utilization and medical variation in End of Life care in Cancer patients, which was not associated with GP care or long term care.read more
Study into better protection for healthcare workers against coronavirus infection19 March 2020
Radboudumc and UMC Utrecht will investigate whether health care workers are better protected against the coronavirus after a vaccination against tuberculosis (BCG vaccine). This vaccine does not directly protect against the coronavirus, but provides a boost to the immune system.read more
Differences in the placental disposition of TNF inhibitors uncovered19 March 2020
In Clinical Pharmacology and Therapeutics, researchers from the Depts. of Pharmacology and Toxicology, Obstetrics and Gynecology, and Health Evidence, in collaboration with Sanquin Diagnostic Services, investigated the placental handling of the TNF inhibitors infliximab and etanercept.read more